MAC Shows Worse Periprocedural Mitral Intervention Outcomes, but TMVI Appears to Improve Technical, Clinical Results – Registry
The presence of mitral annular calcification (MAC) confers worse periprocedural outcomes that last beyond 30 days, but transcatheter mitral valve implantation (TMVI) appears to improve technical and clinical outcomes compared to other transcatheter-based techniques, according to late-breaking trial results presented Wednesday at Transcatheter Valve Therapies (TVT) 2021.